These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5142666)

  • 21. [Progress in drug technology in the years 1968 and 1969].
    Chalabala M; Malý J; Burelová A
    Cesk Farm; 1970 Nov; 19(9):332-60. PubMed ID: 4926371
    [No Abstract]   [Full Text] [Related]  

  • 22. [Formulation of sustained-release tablets. II. Hydrophilic matrices].
    Buri P; Doelker E
    Pharm Acta Helv; 1980; 55(7-8):189-97. PubMed ID: 7433467
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peroral drugs with delayed action. V. Relation between the moulding pressure and the release of drugs].
    Starha L; Chalabala M
    Cesk Farm; 1971 Jan; 20(1):23-5. PubMed ID: 5546597
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in the production and control of tablets. XVII. Native starches as pharmaceutic aids].
    Chalabala M; Heliová M
    Cesk Farm; 1976 May; 25(3-4):125-8. PubMed ID: 947558
    [No Abstract]   [Full Text] [Related]  

  • 25. [Advances in the production and control of tablets. XVI. Various types of oral preparations with delayed action].
    Chalabala M; Vitková M
    Cesk Farm; 1976 Mar; 25(2):79-81. PubMed ID: 1277318
    [No Abstract]   [Full Text] [Related]  

  • 26. [Formulation of slow-release tablets. III. Lipid matrices].
    Doelker E; Buri P
    Pharm Acta Helv; 1981; 56(4-5):111-8. PubMed ID: 7255497
    [No Abstract]   [Full Text] [Related]  

  • 27. [Obtaining of prolonged action of drugs based on insoluble matrix].
    Chodkowska-Granicka B; Michalski K; Surowiecki J; Pawlak E; Trojanowska Z
    Acta Pol Pharm; 1970; 27(3):285-90. PubMed ID: 5456904
    [No Abstract]   [Full Text] [Related]  

  • 28. [Release insoluble drugs from the hydrophobic tablet matrix. 1].
    Schekerdjiski R; Trandafilov A; Michailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):632-4. PubMed ID: 5149134
    [No Abstract]   [Full Text] [Related]  

  • 29. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X; Sun M; Zhi F; Hu Y
    Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of tablets. IV. Influence of the nature and proportion of some adjuvants on phenobarbital grain and tablet qualities].
    Clerc J; Duchêne D; Puisieux F
    Ann Pharm Fr; 1970 Dec; 28(12):719-28. PubMed ID: 5516406
    [No Abstract]   [Full Text] [Related]  

  • 33. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Release insoluble drugs from the hydrophobic tablet matrix. 2. Influence of non-ionogenic surface-active substances].
    Schekerdjiski R; Minkov E; Mihailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):635-6. PubMed ID: 5149135
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tablets of 7-(3'-(methylhydroxyethylamino)-2'-hydroxypropyl)-theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives].
    Pawlak E; Chodkowska-Granicka B; Surowiecki J
    Acta Pol Pharm; 1971; 28(1):43-7. PubMed ID: 5577811
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on tablets. XXVII. Study on the deformative tension in the compression of aminophenazone tablets].
    Rak J; Chalabala M; Heliová M; Mandák M
    Cesk Farm; 1977 Jun; 26(5):170-4. PubMed ID: 908071
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled drug release in veterinary medicines by means of carboxyvinylpolymers].
    Perotti AG
    Farmaco Prat; 1976 Mar; 31(3):111-22. PubMed ID: 1253956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.